Skip to main content

Table 3 The table describes the demographic data available for the matched control cohortasecond transplant in 2003

From: Long-term clinical outcome for patients poisoned by the fungal nephrotoxin orellanine

A. Matched control patients who had hemodialysis
No#: Born year Transplant 1 Diagnosis Follow up M Follow up Y Death Y CoD Cancer
1 1935 1980 PCK 356 30 2010 Peritonitis Y
2 1925 1986 Amylioidosis 95 8 1994 Unknown Y
3 1965 2002 Crescentic GN 141 12    N
4 1953 2012 IgAN 20 2    N
5 1958 2012 PCK 22 2    N
6 1955 2009 PCK 59 5    N
7 1942 1983 Pyelonephritis 368 31    
8 1972 1988a PCK 307 26    N
9 1970 2000 Interstitial Nephritis 156 13    
10 1973 2001 IgAN 194 16    
11 1952 1992 IgAN 157 13 2005 Epilepsy N
12 1951 1992 Interstitial nephritis 263 22    N
13 1971 1992 CGN 260 22    
B. Matched control patients who had a renal transplantation
No#: Born year HD start Diagnosis Follow up M Follow up Y Death Y CoD Cancer
14 1925 1984 CVD 160 13 1997 Cancer Y
15 1916 1984 Heredetary nephropaty 139 12 1996 Sepsis  
16 1962 1985 Glomerulonephritis 343 29    Y
17 1942 1987 CVD 72 6 1993 CVD  
18 1965 1990 Glomerulonephritis 284 24    
19 1952 1999 Glomerulonephritis 178 15    
20 1973 2011 Interstitial nephritis 29 2    N
  1. aSecond transplant in 2003, M: months, Y: year, PCK:polycystic kidney disease, Crescentic GN: crescentic glomerulonephritis, IgAN: IgA nephritis, CGN: Chronic glomerulonephritis, CoD: cause of death, CVD: cardiovascular disease
  2. The cohort was matched based on age, sex and A. initiation of hemodialysis or B. renal transplantation